CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?

Patients with advanced heart failure (HF) have high mortality rates, to a relatively greater extent in those with New York Heart Association (NYHA) functional class IV versus III, justifying consideration of cardiac transplantation in this high-risk population.1,2 For many of these patients, gains in pharmacologic therapy have helped significantly in… CONTINUE READING